Top Markets
#1 Cortex Cortex +32.92%
#2 EXOD EXOD +9.04%
#3 peaq peaq +7.65%
#4 Seeker Seeker +6.81%
#5 MarsCoin MarsCoin +6.69%
#6 Ethena Staked ENA Ethena Staked ENA +5.92%
#7 DexNet DexNet +5.76%
#8 ETHGas ETHGas +5.33%
#9 Versatize Coin Versatize Coin +5.26%
#10 aelf aelf +4.88%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Qingdao Baheal Medical Inc. Qingdao Baheal Medical Inc.

Qingdao Baheal Medical Inc.

301015
Rangering i aksjer #6756
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao,... Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Aksjekurs
$3.56
Sist synkronisert: 2026-08-27
Markedsverdi
$1.87B
Endring (1 dag)
0.41%
Endring (1 år)
2.96%
Land
CN
Handel Qingdao Baheal Medical Inc. (301015)

Kategori

Healthcare
P/B-forhold for Qingdao Baheal Medical Inc. (301015)
P/B-forhold per 2026 TTM: 0
Ifølge Qingdao Baheal Medical Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Qingdao Baheal Medical Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US